Robert Willis

Quantitative Pharamcology Experimental Medicines Unit Immuno-Inflammation Therapy Area

Quantitative Pharamcology Experimental Medicines Unit Immuno-Inflammation Therapy Area Working within the EMU as a DMPK representative on a multi-functional lead optimisation drug discovery programme team. Responsible for the design and implementation of key DMPK and in vivo efficacy studies to evaluate molecules from SOC through LO to deliver candidate quality molecules including:- Efficiently conducting in vivo DMPK studies ensuring timely reporting of data and interpretations to key stakeholders within the programme team Provide DMPK strategic input to enable key programme progression decisions Authoring scientific reports to support candidate selection Integrate in vivo and in vitro DMPK data, identify correlations and understand limitations As a member of a small cross functional quantitative pharmacology team provide quality DMPK input to successfully develop and optimise in vivo efficacy models to establish early PK/PD relationships for multiple disease programmes across the DPU portfolio.